We are live on ! Find out more
PLRX icon

Pliant Therapeutics
PLRX

81 hedge funds and large institutions have $893M invested in Pliant Therapeutics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 23 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

33% more funds holding in top 10

Funds holding in top 10: 3 → 4 (+1)

17% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 23

7% more funds holding

Funds holding: 76 → 81 (+5)

0.44% less ownership

Funds ownership: 85.95% → 85.51% (-0.44%)

26% less capital invested

Capital invested by funds: $1.21B → $893M (-$314M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $189K

Holders
81
Holders Change
+5
Holders Change %
+6.58%
% of All Funds
1.41%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
12
Increased
27
Reduced
23
Closed
7
Calls
–
Puts
$189K
Net Calls
-$189K
Net Calls Change
-$189K

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$5.26M
2
FIM
Fernwood Investment Management
Massachusetts
+$4.7M
3
BDFN
Bond & Devick Financial Network
Minnesota
+$3.74M
4
WP
Woodline Partners
California
+$2.23M
5
SFM
Sphera Funds Management
Israel
+$1.59M

Top Sellers

1
FCM
Farallon Capital Management
California
-$8.54M
2
CAM
Cormorant Asset Management
Massachusetts
-$4.02M
3
BlackRock
BlackRock
New York
-$3.65M
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$3.63M
5
RG
Redmile Group
California
-$1.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
WP
26
Woodline Partners
California
$2.09M +$2.23M +71,663 New
Bank of New York Mellon
27
Bank of New York Mellon
New York
$1.73M -$3.63M -116,658 -66%
GC
28
Grace Capital
Massachusetts
$1.68M +$612K +19,650 +51%
SFM
29
Sphera Funds Management
Israel
$1.49M +$1.59M +51,000 New
Wells Fargo
30
Wells Fargo
California
$1.22M +$333K +10,694 +34%
Morgan Stanley
31
Morgan Stanley
New York
$982K +$914K +29,372 +679%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$966K -$95.3K -3,063 -8%
PCM
33
Pentwater Capital Management
Florida
$874K – – –
Russell Investments Group
34
Russell Investments Group
United Kingdom
$848K +$908K +29,182 New
Swiss National Bank
35
Swiss National Bank
Switzerland
$798K +$106K +3,400 +14%
Goldman Sachs
36
Goldman Sachs
New York
$739K +$333K +10,689 +73%
AllianceBernstein
37
AllianceBernstein
Tennessee
$708K +$34.2K +1,100 +5%
RhumbLine Advisers
38
RhumbLine Advisers
Massachusetts
$634K -$71K -2,282 -9%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$632K +$93.1K +2,991 +16%
Millennium Management
40
Millennium Management
New York
$504K -$1.43M -46,047 -73%
Deutsche Bank
41
Deutsche Bank
Germany
$435K -$26.4K -849 -5%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$428K – – –
ECM
43
ExodusPoint Capital Management
New York
$422K +$451K +14,499 New
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$397K +$8.62K +277 +2%
BFM
45
Boothbay Fund Management
New York
$396K +$26.3K +845 +7%
JP Morgan Chase
46
JP Morgan Chase
New York
$382K -$516K -16,570 -56%
ProShare Advisors
47
ProShare Advisors
Maryland
$370K +$42.5K +1,364 +12%
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$333K – – –
TD Asset Management
49
TD Asset Management
Ontario, Canada
$292K – – –
VOYA Investment Management
50
VOYA Investment Management
Georgia
$288K -$13.5K -433 -4%
1
2
3 4

PLRX Hedge Fund Activity: Q2 2021 in Review

81 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Pliant Therapeutics (PLRX) for Q2 2021, worth a combined $893M — down 26% from $1.21B a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new PLRX positions and 7 closed out — a net gain of 5 holders — while 27 added to existing stakes and 23 trimmed.

The largest buyer was Vanguard Group, adding an estimated $5.26M. The largest seller was Farallon Capital Management, cutting an estimated $8.54M.

  • 81 institutional investors held Pliant Therapeutics (PLRX) as of Q2 2021, up from 76 in Q1 2021.
  • Funds reported $893M of Pliant Therapeutics stock for Q2 2021, down 26% quarter-over-quarter.
  • 12 funds opened new Pliant Therapeutics positions in Q2 2021 and 7 closed out, a net change of +5 holders.
  • The largest Pliant Therapeutics buyer in Q2 2021 was Vanguard Group, an estimated $5.26M added.
  • The largest Pliant Therapeutics seller in Q2 2021 was Farallon Capital Management, an estimated $8.54M sold.

Based on aggregated 13F filings for Q2 2021.